Global Ayurvedic Herbs Market

Ayurvedic Herbs Comprehensive Study by Type (Withania Somnifera (Ashwagandha), Frankincense (Boswellia), Indian Gooseberry (Triphala), Bacopa Monnieri (Brahmi), Turmeric, Cumin, Bitter Melon, Others), Form (Raw, Capsules/Tablets, Extracts), Sales Channel (Business to Business, Business to Consumer), Disease Indication (Cardiovascular Diseases, Inflammatory Diseases, Diabetes, Infectious Diseases, Auto-Immune Diseases, Skin Diseases, Others) Players and Region - Global Market Outlook to 2028

Ayurvedic Herbs Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Ayurvedic Herbs
The Ayurvedic herbs market growth is propelled by rising in consumer health consciousness and an improved distribution network. shoppers are ready to pay a lot of for those merchandise that give health advantages, and this awareness is expected to be a driver for the Ayurvedic herbal products market development. Ayurvedic Herbs and their products are still in emergent stages in varied western countries like Argentina, Canada, and Peru alongside different developing regions. These are still untapped, which present lucrative Ayurvedic herbs market opportunities for manufacturers of Ayurvedic herbs products. Growing attention to alternative medicine is creating opportunities and Ayurvedic herbs market trends for the natural ingredients in coming years.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


Growing attention to alternative medicine is creating opportunities and Ayurvedic herbs market trends for the natural ingredients in coming years. There is an opportunity for suppliers of natural ingredients in developing countries, especially since some ingredients are not grown in Europe. The herbal and ayurvedic herbs are being demanded in the market Analyst at AMA Research estimates that Indian Vendors will contribute the maximum growth to Global Ayurvedic Herbs market throughout the forecasted period. Established and emerging Vendors should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Colgate-Palmolive Company (United States), Dabur India Ltd. (India), Emami Limited (India), Kairali Ayurvedic Group (India), P&G (United States), Patanjali Ayurved Limited (India), Shahnaz Ayurveda Pvt. Ltd (India), Shree Baidyanath Ayurveda Bhawan Pvt. Ltd (India), The Himalaya Drug Company (India) and Unilever (United Kingdom) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Ayurvedic Herbs market by Type (Withania Somnifera (Ashwagandha), Frankincense (Boswellia), Indian Gooseberry (Triphala), Bacopa Monnieri (Brahmi), Turmeric, Cumin, Bitter Melon and Others) and Region.



On the basis of geography, the market of Ayurvedic Herbs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Form, the sub-segment i.e. Raw will boost the Ayurvedic Herbs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Sales Channel, the sub-segment i.e. Business to Business will boost the Ayurvedic Herbs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Disease Indication, the sub-segment i.e. Cardiovascular Diseases will boost the Ayurvedic Herbs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Trends to Adopt the Natural Ingredients and Increasing Adoption by The Developing Countries

Market Growth Drivers:
Increase In Disposable Income and Increase In Awareness About the Health Benefits

Challenges:
Intense Competition in The Market

Restraints:
High Cost of The Herbs

Opportunities:
Increased Scientific Research and Development Activities

Market Leaders and their expansionary development strategies
In October 2023, Himalaya Drug Company and The Himalaya Drug Research Institute signed a partnership agreement to develop new ayurvedic herbal medicines. The two organizations will combine their expertise in traditional Indian medicine and modern science to develop new treatments for a variety of diseases.
In September 2023, Dabur India Ltd. acquired Baidyanath Group. This acquisition will strengthen Dabur's position in the ayurvedic herbs market and expand its reach into the northern Indian market.


Key Target Audience
Manufacturers of Ayurvedic Herbs, Suppliers and distributors of Ayurvedic Herbs, Vendors of Ayurvedic Herbs, Raw Material Supplier of Ayurvedic Herbs, Governmental and Regulatory bodies and End-Users

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Withania Somnifera (Ashwagandha)
  • Frankincense (Boswellia)
  • Indian Gooseberry (Triphala)
  • Bacopa Monnieri (Brahmi)
  • Turmeric
  • Cumin
  • Bitter Melon
  • Others
By Form
  • Raw
  • Capsules/Tablets
  • Extracts

By Sales Channel
  • Business to Business
  • Business to Consumer

By Disease Indication
  • Cardiovascular Diseases
  • Inflammatory Diseases
  • Diabetes
  • Infectious Diseases
  • Auto-Immune Diseases
  • Skin Diseases
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase In Disposable Income
      • 3.2.2. Increase In Awareness About the Health Benefits
    • 3.3. Market Challenges
      • 3.3.1. Intense Competition in The Market
    • 3.4. Market Trends
      • 3.4.1. Increasing Trends to Adopt the Natural Ingredients
      • 3.4.2. Increasing Adoption by The Developing Countries
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Ayurvedic Herbs, by Type, Form, Sales Channel, Disease Indication and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Ayurvedic Herbs (Value)
      • 5.2.1. Global Ayurvedic Herbs by: Type (Value)
        • 5.2.1.1. Withania Somnifera (Ashwagandha)
        • 5.2.1.2. Frankincense (Boswellia)
        • 5.2.1.3. Indian Gooseberry (Triphala)
        • 5.2.1.4. Bacopa Monnieri (Brahmi)
        • 5.2.1.5. Turmeric
        • 5.2.1.6. Cumin
        • 5.2.1.7. Bitter Melon
        • 5.2.1.8. Others
      • 5.2.2. Global Ayurvedic Herbs by: Form (Value)
        • 5.2.2.1. Raw
        • 5.2.2.2. Capsules/Tablets
        • 5.2.2.3. Extracts
      • 5.2.3. Global Ayurvedic Herbs by: Sales Channel (Value)
        • 5.2.3.1. Business to Business
        • 5.2.3.2. Business to Consumer
      • 5.2.4. Global Ayurvedic Herbs by: Disease Indication (Value)
        • 5.2.4.1. Cardiovascular Diseases
        • 5.2.4.2. Inflammatory Diseases
        • 5.2.4.3. Diabetes
        • 5.2.4.4. Infectious Diseases
        • 5.2.4.5. Auto-Immune Diseases
        • 5.2.4.6. Skin Diseases
        • 5.2.4.7. Others
      • 5.2.5. Global Ayurvedic Herbs Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Ayurvedic Herbs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Colgate-Palmolive Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Dabur India Ltd. (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Emami Limited (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Kairali Ayurvedic Group (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. P&G (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Patanjali Ayurved Limited (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Shahnaz Ayurveda Pvt. Ltd (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Shree Baidyanath Ayurveda Bhawan Pvt. Ltd (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. The Himalaya Drug Company (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Unilever (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Ayurvedic Herbs Sale, by Type, Form, Sales Channel, Disease Indication and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Ayurvedic Herbs (Value)
      • 7.2.1. Global Ayurvedic Herbs by: Type (Value)
        • 7.2.1.1. Withania Somnifera (Ashwagandha)
        • 7.2.1.2. Frankincense (Boswellia)
        • 7.2.1.3. Indian Gooseberry (Triphala)
        • 7.2.1.4. Bacopa Monnieri (Brahmi)
        • 7.2.1.5. Turmeric
        • 7.2.1.6. Cumin
        • 7.2.1.7. Bitter Melon
        • 7.2.1.8. Others
      • 7.2.2. Global Ayurvedic Herbs by: Form (Value)
        • 7.2.2.1. Raw
        • 7.2.2.2. Capsules/Tablets
        • 7.2.2.3. Extracts
      • 7.2.3. Global Ayurvedic Herbs by: Sales Channel (Value)
        • 7.2.3.1. Business to Business
        • 7.2.3.2. Business to Consumer
      • 7.2.4. Global Ayurvedic Herbs by: Disease Indication (Value)
        • 7.2.4.1. Cardiovascular Diseases
        • 7.2.4.2. Inflammatory Diseases
        • 7.2.4.3. Diabetes
        • 7.2.4.4. Infectious Diseases
        • 7.2.4.5. Auto-Immune Diseases
        • 7.2.4.6. Skin Diseases
        • 7.2.4.7. Others
      • 7.2.5. Global Ayurvedic Herbs Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Ayurvedic Herbs: by Type(USD Million)
  • Table 2. Ayurvedic Herbs Withania Somnifera (Ashwagandha) , by Region USD Million (2017-2022)
  • Table 3. Ayurvedic Herbs Frankincense (Boswellia) , by Region USD Million (2017-2022)
  • Table 4. Ayurvedic Herbs Indian Gooseberry (Triphala) , by Region USD Million (2017-2022)
  • Table 5. Ayurvedic Herbs Bacopa Monnieri (Brahmi) , by Region USD Million (2017-2022)
  • Table 6. Ayurvedic Herbs Turmeric , by Region USD Million (2017-2022)
  • Table 7. Ayurvedic Herbs Cumin , by Region USD Million (2017-2022)
  • Table 8. Ayurvedic Herbs Bitter Melon , by Region USD Million (2017-2022)
  • Table 9. Ayurvedic Herbs Others , by Region USD Million (2017-2022)
  • Table 10. Ayurvedic Herbs: by Form(USD Million)
  • Table 11. Ayurvedic Herbs Raw , by Region USD Million (2017-2022)
  • Table 12. Ayurvedic Herbs Capsules/Tablets , by Region USD Million (2017-2022)
  • Table 13. Ayurvedic Herbs Extracts , by Region USD Million (2017-2022)
  • Table 14. Ayurvedic Herbs: by Sales Channel(USD Million)
  • Table 15. Ayurvedic Herbs Business to Business , by Region USD Million (2017-2022)
  • Table 16. Ayurvedic Herbs Business to Consumer , by Region USD Million (2017-2022)
  • Table 17. Ayurvedic Herbs: by Disease Indication(USD Million)
  • Table 18. Ayurvedic Herbs Cardiovascular Diseases , by Region USD Million (2017-2022)
  • Table 19. Ayurvedic Herbs Inflammatory Diseases , by Region USD Million (2017-2022)
  • Table 20. Ayurvedic Herbs Diabetes , by Region USD Million (2017-2022)
  • Table 21. Ayurvedic Herbs Infectious Diseases , by Region USD Million (2017-2022)
  • Table 22. Ayurvedic Herbs Auto-Immune Diseases , by Region USD Million (2017-2022)
  • Table 23. Ayurvedic Herbs Skin Diseases , by Region USD Million (2017-2022)
  • Table 24. Ayurvedic Herbs Others , by Region USD Million (2017-2022)
  • Table 25. South America Ayurvedic Herbs, by Country USD Million (2017-2022)
  • Table 26. South America Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 27. South America Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 28. South America Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 29. South America Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 30. Brazil Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 31. Brazil Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 32. Brazil Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 33. Brazil Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 34. Argentina Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 35. Argentina Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 36. Argentina Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 37. Argentina Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 38. Rest of South America Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 39. Rest of South America Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 40. Rest of South America Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 41. Rest of South America Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 42. Asia Pacific Ayurvedic Herbs, by Country USD Million (2017-2022)
  • Table 43. Asia Pacific Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 44. Asia Pacific Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 45. Asia Pacific Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 46. Asia Pacific Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 47. China Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 48. China Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 49. China Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 50. China Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 51. Japan Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 52. Japan Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 53. Japan Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 54. Japan Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 55. India Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 56. India Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 57. India Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 58. India Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 59. South Korea Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 60. South Korea Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 61. South Korea Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 62. South Korea Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 63. Taiwan Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 64. Taiwan Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 65. Taiwan Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 66. Taiwan Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 67. Australia Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 68. Australia Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 69. Australia Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 70. Australia Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 71. Rest of Asia-Pacific Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 72. Rest of Asia-Pacific Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 73. Rest of Asia-Pacific Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 74. Rest of Asia-Pacific Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 75. Europe Ayurvedic Herbs, by Country USD Million (2017-2022)
  • Table 76. Europe Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 77. Europe Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 78. Europe Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 79. Europe Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 80. Germany Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 81. Germany Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 82. Germany Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 83. Germany Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 84. France Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 85. France Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 86. France Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 87. France Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 88. Italy Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 89. Italy Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 90. Italy Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 91. Italy Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 92. United Kingdom Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 93. United Kingdom Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 94. United Kingdom Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 95. United Kingdom Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 96. Netherlands Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 97. Netherlands Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 98. Netherlands Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 99. Netherlands Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 100. Rest of Europe Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 101. Rest of Europe Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 102. Rest of Europe Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 103. Rest of Europe Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 104. MEA Ayurvedic Herbs, by Country USD Million (2017-2022)
  • Table 105. MEA Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 106. MEA Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 107. MEA Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 108. MEA Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 109. Middle East Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 110. Middle East Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 111. Middle East Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 112. Middle East Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 113. Africa Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 114. Africa Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 115. Africa Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 116. Africa Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 117. North America Ayurvedic Herbs, by Country USD Million (2017-2022)
  • Table 118. North America Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 119. North America Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 120. North America Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 121. North America Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 122. United States Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 123. United States Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 124. United States Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 125. United States Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 126. Canada Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 127. Canada Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 128. Canada Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 129. Canada Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 130. Mexico Ayurvedic Herbs, by Type USD Million (2017-2022)
  • Table 131. Mexico Ayurvedic Herbs, by Form USD Million (2017-2022)
  • Table 132. Mexico Ayurvedic Herbs, by Sales Channel USD Million (2017-2022)
  • Table 133. Mexico Ayurvedic Herbs, by Disease Indication USD Million (2017-2022)
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Ayurvedic Herbs: by Type(USD Million)
  • Table 145. Ayurvedic Herbs Withania Somnifera (Ashwagandha) , by Region USD Million (2023-2028)
  • Table 146. Ayurvedic Herbs Frankincense (Boswellia) , by Region USD Million (2023-2028)
  • Table 147. Ayurvedic Herbs Indian Gooseberry (Triphala) , by Region USD Million (2023-2028)
  • Table 148. Ayurvedic Herbs Bacopa Monnieri (Brahmi) , by Region USD Million (2023-2028)
  • Table 149. Ayurvedic Herbs Turmeric , by Region USD Million (2023-2028)
  • Table 150. Ayurvedic Herbs Cumin , by Region USD Million (2023-2028)
  • Table 151. Ayurvedic Herbs Bitter Melon , by Region USD Million (2023-2028)
  • Table 152. Ayurvedic Herbs Others , by Region USD Million (2023-2028)
  • Table 153. Ayurvedic Herbs: by Form(USD Million)
  • Table 154. Ayurvedic Herbs Raw , by Region USD Million (2023-2028)
  • Table 155. Ayurvedic Herbs Capsules/Tablets , by Region USD Million (2023-2028)
  • Table 156. Ayurvedic Herbs Extracts , by Region USD Million (2023-2028)
  • Table 157. Ayurvedic Herbs: by Sales Channel(USD Million)
  • Table 158. Ayurvedic Herbs Business to Business , by Region USD Million (2023-2028)
  • Table 159. Ayurvedic Herbs Business to Consumer , by Region USD Million (2023-2028)
  • Table 160. Ayurvedic Herbs: by Disease Indication(USD Million)
  • Table 161. Ayurvedic Herbs Cardiovascular Diseases , by Region USD Million (2023-2028)
  • Table 162. Ayurvedic Herbs Inflammatory Diseases , by Region USD Million (2023-2028)
  • Table 163. Ayurvedic Herbs Diabetes , by Region USD Million (2023-2028)
  • Table 164. Ayurvedic Herbs Infectious Diseases , by Region USD Million (2023-2028)
  • Table 165. Ayurvedic Herbs Auto-Immune Diseases , by Region USD Million (2023-2028)
  • Table 166. Ayurvedic Herbs Skin Diseases , by Region USD Million (2023-2028)
  • Table 167. Ayurvedic Herbs Others , by Region USD Million (2023-2028)
  • Table 168. South America Ayurvedic Herbs, by Country USD Million (2023-2028)
  • Table 169. South America Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 170. South America Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 171. South America Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 172. South America Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 173. Brazil Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 174. Brazil Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 175. Brazil Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 176. Brazil Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 177. Argentina Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 178. Argentina Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 179. Argentina Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 180. Argentina Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 181. Rest of South America Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 182. Rest of South America Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 183. Rest of South America Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 184. Rest of South America Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 185. Asia Pacific Ayurvedic Herbs, by Country USD Million (2023-2028)
  • Table 186. Asia Pacific Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 187. Asia Pacific Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 188. Asia Pacific Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 189. Asia Pacific Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 190. China Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 191. China Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 192. China Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 193. China Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 194. Japan Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 195. Japan Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 196. Japan Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 197. Japan Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 198. India Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 199. India Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 200. India Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 201. India Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 202. South Korea Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 203. South Korea Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 204. South Korea Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 205. South Korea Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 206. Taiwan Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 207. Taiwan Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 208. Taiwan Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 209. Taiwan Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 210. Australia Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 211. Australia Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 212. Australia Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 213. Australia Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 214. Rest of Asia-Pacific Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 215. Rest of Asia-Pacific Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 216. Rest of Asia-Pacific Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 217. Rest of Asia-Pacific Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 218. Europe Ayurvedic Herbs, by Country USD Million (2023-2028)
  • Table 219. Europe Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 220. Europe Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 221. Europe Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 222. Europe Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 223. Germany Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 224. Germany Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 225. Germany Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 226. Germany Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 227. France Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 228. France Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 229. France Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 230. France Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 231. Italy Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 232. Italy Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 233. Italy Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 234. Italy Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 235. United Kingdom Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 236. United Kingdom Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 237. United Kingdom Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 238. United Kingdom Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 239. Netherlands Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 240. Netherlands Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 241. Netherlands Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 242. Netherlands Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 243. Rest of Europe Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 244. Rest of Europe Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 245. Rest of Europe Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 246. Rest of Europe Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 247. MEA Ayurvedic Herbs, by Country USD Million (2023-2028)
  • Table 248. MEA Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 249. MEA Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 250. MEA Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 251. MEA Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 252. Middle East Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 253. Middle East Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 254. Middle East Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 255. Middle East Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 256. Africa Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 257. Africa Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 258. Africa Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 259. Africa Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 260. North America Ayurvedic Herbs, by Country USD Million (2023-2028)
  • Table 261. North America Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 262. North America Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 263. North America Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 264. North America Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 265. United States Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 266. United States Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 267. United States Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 268. United States Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 269. Canada Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 270. Canada Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 271. Canada Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 272. Canada Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 273. Mexico Ayurvedic Herbs, by Type USD Million (2023-2028)
  • Table 274. Mexico Ayurvedic Herbs, by Form USD Million (2023-2028)
  • Table 275. Mexico Ayurvedic Herbs, by Sales Channel USD Million (2023-2028)
  • Table 276. Mexico Ayurvedic Herbs, by Disease Indication USD Million (2023-2028)
  • Table 277. Research Programs/Design for This Report
  • Table 278. Key Data Information from Secondary Sources
  • Table 279. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Ayurvedic Herbs: by Type USD Million (2017-2022)
  • Figure 5. Global Ayurvedic Herbs: by Form USD Million (2017-2022)
  • Figure 6. Global Ayurvedic Herbs: by Sales Channel USD Million (2017-2022)
  • Figure 7. Global Ayurvedic Herbs: by Disease Indication USD Million (2017-2022)
  • Figure 8. South America Ayurvedic Herbs Share (%), by Country
  • Figure 9. Asia Pacific Ayurvedic Herbs Share (%), by Country
  • Figure 10. Europe Ayurvedic Herbs Share (%), by Country
  • Figure 11. MEA Ayurvedic Herbs Share (%), by Country
  • Figure 12. North America Ayurvedic Herbs Share (%), by Country
  • Figure 13. Global Ayurvedic Herbs share by Players 2022 (%)
  • Figure 14. Global Ayurvedic Herbs share by Players (Top 3) 2022(%)
  • Figure 15. Global Ayurvedic Herbs share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Colgate-Palmolive Company (United States) Revenue, Net Income and Gross profit
  • Figure 18. Colgate-Palmolive Company (United States) Revenue: by Geography 2022
  • Figure 19. Dabur India Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 20. Dabur India Ltd. (India) Revenue: by Geography 2022
  • Figure 21. Emami Limited (India) Revenue, Net Income and Gross profit
  • Figure 22. Emami Limited (India) Revenue: by Geography 2022
  • Figure 23. Kairali Ayurvedic Group (India) Revenue, Net Income and Gross profit
  • Figure 24. Kairali Ayurvedic Group (India) Revenue: by Geography 2022
  • Figure 25. P&G (United States) Revenue, Net Income and Gross profit
  • Figure 26. P&G (United States) Revenue: by Geography 2022
  • Figure 27. Patanjali Ayurved Limited (India) Revenue, Net Income and Gross profit
  • Figure 28. Patanjali Ayurved Limited (India) Revenue: by Geography 2022
  • Figure 29. Shahnaz Ayurveda Pvt. Ltd (India) Revenue, Net Income and Gross profit
  • Figure 30. Shahnaz Ayurveda Pvt. Ltd (India) Revenue: by Geography 2022
  • Figure 31. Shree Baidyanath Ayurveda Bhawan Pvt. Ltd (India) Revenue, Net Income and Gross profit
  • Figure 32. Shree Baidyanath Ayurveda Bhawan Pvt. Ltd (India) Revenue: by Geography 2022
  • Figure 33. The Himalaya Drug Company (India) Revenue, Net Income and Gross profit
  • Figure 34. The Himalaya Drug Company (India) Revenue: by Geography 2022
  • Figure 35. Unilever (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 36. Unilever (United Kingdom) Revenue: by Geography 2022
  • Figure 37. Global Ayurvedic Herbs: by Type USD Million (2023-2028)
  • Figure 38. Global Ayurvedic Herbs: by Form USD Million (2023-2028)
  • Figure 39. Global Ayurvedic Herbs: by Sales Channel USD Million (2023-2028)
  • Figure 40. Global Ayurvedic Herbs: by Disease Indication USD Million (2023-2028)
  • Figure 41. South America Ayurvedic Herbs Share (%), by Country
  • Figure 42. Asia Pacific Ayurvedic Herbs Share (%), by Country
  • Figure 43. Europe Ayurvedic Herbs Share (%), by Country
  • Figure 44. MEA Ayurvedic Herbs Share (%), by Country
  • Figure 45. North America Ayurvedic Herbs Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Colgate-Palmolive Company (United States)
  • Dabur India Ltd. (India)
  • Emami Limited (India)
  • Kairali Ayurvedic Group (India)
  • P&G (United States)
  • Patanjali Ayurved Limited (India)
  • Shahnaz Ayurveda Pvt. Ltd (India)
  • Shree Baidyanath Ayurveda Bhawan Pvt. Ltd (India)
  • The Himalaya Drug Company (India)
  • Unilever (United Kingdom)
Select User Access Type

Key Highlights of Report


Nov 2023 221 Pages 91 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Ayurvedic Herbs Market Quantitative research analysis
Global Ayurvedic Herbs Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Colgate-Palmolive Company (United States), Dabur India Ltd. (India), Emami Limited (India), Kairali Ayurvedic Group (India), P&G (United States), Patanjali Ayurved Limited (India), Shahnaz Ayurveda Pvt. Ltd (India), Shree Baidyanath Ayurveda Bhawan Pvt. Ltd (India), The Himalaya Drug Company (India) and Unilever (United Kingdom) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Trends to Adopt the Natural Ingredients " is seen as one of major influencing trends for Ayurvedic Herbs Market during projected period 2022-2028.
The Ayurvedic Herbs market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Ayurvedic Herbs Market Report?

Have a Query? Click Here

Other Related Reports

Dog Clothing and Accessories Comprehensive Study by Type (Sweaters & Jackets, Raincoat, Collars, Toys, Bedding, Others), Category (Apparel Accessories, Outwear & Costumes), Distribution Channel (E-Co...
$ 3650
Cleanroom Goggles Comprehensive Study by Type (Single-Use, Reusable), Application (Electronic and Semiconductor, Pharmaceutical and Biotechnology, Medical Device Industry, Others), Distribution Chann...
$ 3650
Biodegradable Water Bottles Comprehensive Study by Application (Residential, Institutional, Sports, Travel, Gym, Others), Biodegradable Plastic (Starch-based Plastics, Polylactic Acid {PLA}, Poly-but...
$ 3650
Animal Wax Candle Comprehensive Study by Type (Beewax, Spermaceti Wax, Other), Application (Traditional Field, Craft Field), Distribution Channel (Online, Offline), Fragrance (Scented, Not-Scented) P...
$ 3500
Mafura Butter Comprehensive Study by Application (Personal care products (Skin care, Hair care), Pharmaceuticals, Animal care products, Edible oils, Home care products (Candles, Wood polish, Others))...
$ 3450
Tipping Kettle Comprehensive Study by Type (Heatable, Non-heatable), Application (Household, Commercial), Distribution Channel (Online Stores, Offline Stores) Players and Region - Global Market Outlo...
$ 3500